Literature DB >> 18613538

Epidemiological aspects and risk factors of toxocariasis in a pediatric population in Sri Lanka.

S D Fernando1, V P Wickramasinghe, G M G Kapilananda, R L Devasurendra, J D M S Amarasooriya, H G A K Dayaratne.   

Abstract

This cross-sectional study, carried out over a period of 11 months, investigated the relationship between Toxocara seropositivity, socio-demographic and environmental variables in a pediatric population. Risk factors for Toxocara infection were assessed by direct interview of parent or guardian using a structured pre-tested questionnaire. Eosinophilia and presence of helminth eggs or protozoan cysts in a fecal smear were recorded. Diagnosis of Toxocara seropositivity in children was based on IgG Toxocara Microwell Serum Elisa Kits. The ELISA test was regarded as positive if the optical density was 0.3 units or above. Unadjusted and adjusted odds ratios were calculated to determine risk factors for disease. The proportion of children who were positive for Toxocara antibodies in the study population was 20%. Children being exposed to a puppy of less than 3 months at home, visiting a playground frequently, living in a poorly constructed house and dogs having access to playgrounds were significant risk factors on univariate analysis. Of these four variables, only the first three variables (OR 19, OR 4 and OR 3, respectively) remained significant risk factors on the multivariate model. Presence of eosinophilia in seropositive children was significantly higher than the seronegative group (77% vs 40%; p < 0.001). This study indicates that dogs contribute significantly to children being seropositive for toxocariasis in Sri Lanka. Implementation of public health programs specifically focused on anti-parasitic treatment of dogs is recommended.

Entities:  

Mesh:

Year:  2007        PMID: 18613538

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  7 in total

1.  Serological studies of neurologic helminthic infections in rural areas of southwest cameroon: toxocariasis, cysticercosis and paragonimiasis.

Authors:  Agathe Nkouawa; Yasuhito Sako; Sonoyo Itoh; Alida Kouojip-Mabou; Christ Nadège Nganou; Yasuaki Saijo; Jenny Knapp; Hiroshi Yamasaki; Minoru Nakao; Kazuhiro Nakaya; Roger Moyou-Somo; Akira Ito
Journal:  PLoS Negl Trop Dis       Date:  2010-07-06

2.  Toxoplasma, toxocara and tuberculosis co-infection in a four year old child.

Authors:  Randeewari Guneratne; Devan Mendis; Tharaka Bandara; Sumadhya Deepika Fernando
Journal:  BMC Pediatr       Date:  2011-05-26       Impact factor: 2.125

3.  Frequency of Toxocariasis among Patients Clinically Suspected to Have Visceral Toxocariasis: A Retrospective Descriptive Study in Sri Lanka.

Authors:  Devika Iddawela; Kiruthiha Ehambaram; Dhilma Atapattu; Kalyani Pethiyagoda; Lakmalee Bandara
Journal:  J Parasitol Res       Date:  2017-12-06

Review 4.  Exposure to Animal Feces and Human Health: A Systematic Review and Proposed Research Priorities.

Authors:  Gauthami Penakalapati; Jenna Swarthout; Miranda J Delahoy; Lydia McAliley; Breanna Wodnik; Karen Levy; Matthew C Freeman
Journal:  Environ Sci Technol       Date:  2017-10-09       Impact factor: 9.028

5.  Seroprevalence and modifiable risk factors for Toxocara spp. in Brazilian schoolchildren.

Authors:  Alex J F Cassenote; Alba R de Abreu Lima; José M Pinto Neto; Guita Rubinsky-Elefant
Journal:  PLoS Negl Trop Dis       Date:  2014-05-29

6.  Prevalence of Toxocara antibodies among patients clinically suspected to have ocular toxocariasis: A retrospective descriptive study in Sri Lanka.

Authors:  Devika Iddawela; Kiruthiha Ehambaram; Pemindra Bandara
Journal:  BMC Ophthalmol       Date:  2017-04-24       Impact factor: 2.209

Review 7.  Pathogens transmitted in animal feces in low- and middle-income countries.

Authors:  Miranda J Delahoy; Breanna Wodnik; Lydia McAliley; Gauthami Penakalapati; Jenna Swarthout; Matthew C Freeman; Karen Levy
Journal:  Int J Hyg Environ Health       Date:  2018-03-15       Impact factor: 5.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.